These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8735202)

  • 21. Determining the effects of adulterants on drug detection via enzyme-linked immunosorbent assay and adulterant tests strips.
    Olivieri B; Marić M; Bridge C
    Drug Test Anal; 2018 Sep; 10(9):1383-1393. PubMed ID: 29749024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method comparison of EMIT 700 and EMIT II with RIA for drug screening.
    Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
    J Anal Toxicol; 1994; 18(2):110-7. PubMed ID: 8207931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reagent lot-to-lot variability in sensitivity for amphetamine with the Syva Emit II Monoclonal Amphetamine/Methamphetamine assay.
    Singh J
    J Anal Toxicol; 1997; 21(2):174-5. PubMed ID: 9083839
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous detection of 19 drugs of abuse on dried urine spot by liquid chromatography-tandem mass spectrometry.
    Lee Y; Lai KKY; Sadrzadeh SMH
    Clin Biochem; 2013 Aug; 46(12):1118-1124. PubMed ID: 23583348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira.
    Broussard LA; Hanson L
    Clin Lab Sci; 1997; 10(2):83-6. PubMed ID: 10166356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of adulterants on urine screen for drugs of abuse: detection by an on-site dipstick device.
    Wong R
    Am Clin Lab; 2002; 21(1):37-9. PubMed ID: 11975450
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct detection of drugs of abuse in whole hemolyzed blood using the EMIT d.a.u. urine assays.
    Asselin WM; Leslie JM; McKinley B
    J Anal Toxicol; 1988; 12(4):207-15. PubMed ID: 3054319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicological screening for drugs of abuse in samples adulterated with household chemicals.
    Uebel RA; Wium CA
    S Afr Med J; 2002 Jul; 92(7):547-9. PubMed ID: 12197198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the ETS and ADx urine drug screening immunoassay analyzers.
    Edinboro LE; Hall KV; Poklis A
    J Anal Toxicol; 1989; 13(4):232-4. PubMed ID: 2779176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions among enzyme, antibody, drug, and time in enzyme immunoassays for drugs of abuse.
    Osterloh J; Butrimovitz GP
    Clin Chem; 1982 Feb; 28(2):327-32. PubMed ID: 7035006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Syva ETS Plus urine drug and serum ethanol analyzer.
    Jortani SA; Poklis A
    J Anal Toxicol; 1993; 17(1):31-3. PubMed ID: 8429624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External quality assessment of Syva Emit and Abbott TDx II assays for methotrexate in serum.
    Wilson JF; Tsanaclis LM; Barnett K
    Ther Drug Monit; 1996 Dec; 18(6):721-3. PubMed ID: 8946672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.
    Borgman MP; Hiemer MF; Molinelli AR; Ritchie JC; Jortani SA
    Ther Drug Monit; 2012 Apr; 34(2):193-7. PubMed ID: 22377747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing for drugs of abuse in meconium of newborn infants.
    Moriya F; Chan KM; Noguchi TT; Wu PY
    J Anal Toxicol; 1994; 18(1):41-5. PubMed ID: 8127083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the TRI 'dipstick' test for the detection of drugs of abuse in urine.
    Jukofsky D; Kramer A; Mulé SJ
    J Anal Toxicol; 1981; 5(1):14-9. PubMed ID: 6783782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB; Floyd D; Dasgupta A
    Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
    Schwarzhoff R; Cody JT
    J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.